Peak Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.96M Sell
25,028
-2,697
-10% -$218K 0.29% 64
2026
Q1
$2.4M Sell
27,725
-7,370
-21% -$706K 0.42% 48
2025
Q4
$3.37M Sell
35,095
-315
-0.9% -$30.6K 0.57% 36
2025
Q3
$3.37M Sell
35,410
-1,025
-3% -$94.2K 0.59% 36
2025
Q2
$3.18M Buy
36,435
+7,464
+26% +$633K 0.58% 39
2025
Q1
$2.6M Sell
28,971
-2,810
-9% -$251K 0.5% 45
2024
Q4
$2.54M Sell
31,781
-462
-1% -$40K 0.47% 43
2024
Q3
$2.9M Sell
32,243
-1,248
-4% -$105K 0.55% 41
2024
Q2
$2.64M Sell
33,491
-2,251
-6% -$185K 0.52% 42
2024
Q1
$3.11M Buy
35,742
+708
+2% +$60.4K 0.62% 40
2023
Q4
$2.89M Buy
35,034
+12,589
+56% +$959K 0.64% 40
2023
Q3
$1.76M Buy
+22,445
New +$1.88M 0.42% 58

Other funds holding MDT

Peak Asset Management's MDT Position: Q2 2026 in Review

Peak Asset Management reduced its Medtronic (MDT) stake by 9.7% in Q2 2026, selling an estimated $218K and leaving 25,028 shares worth $1.96M. The position accounts for 0.29% of the portfolio, ranked #64.

Peak Asset Management first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.37M in Q3 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Peak Asset Management held 25,028 shares of Medtronic worth $1.96M as of Q2 2026.
  • Peak Asset Management sold 2,697 Medtronic shares in Q2 2026, an estimated $218K.
  • Medtronic made up 0.29% of Peak Asset Management's portfolio in Q2 2026, its #64 holding.
  • Peak Asset Management first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
  • Peak Asset Management's Medtronic position peaked at $3.37M in Q3 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Peak Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.